CompletedPhase 4NCT01041612
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
Studying Cholangiocarcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Taewoong Medical Co., Ltd.
- Principal Investigator
- Dong Ki Lee, PH.DGangnam Severance Hospital
- Intervention
- PTFE Covered ComVi [full covered] Biliary Stent(device)
- Enrollment
- 120 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2010 – 2012
Study locations (13)
- Gifu University, Gifu, Japan
- Onomichi General Hospital, Onomichi, Japan
- Teine-Keijinkai Hospital, Sapporo, Japan
- The University of Tokyo, Tokyo, Japan
- Toho University, Tokyo, Japan
- Tokyo Medical University, Tokyo, Japan
- Yamaguchi University, Ube, Japan
- Soon Chun Hyang University School of Medicine, Bucheon-si, South Korea
- Soon Chun Hyang University School of Medicine, Cheonan, South Korea
- Catholic University of Daegu School of Medicine, Daegu, South Korea
- Inha University School of Medicine, Incheon, South Korea
- Gangnam Severance Hospital, Seoul, South Korea
- Ajou University School of Medicine, Suwon, South Korea
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01041612 on ClinicalTrials.govOther trials for Cholangiocarcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07478523FAPI-PET Value for the Initial Screening of Pancreatic and Biliary CancersUniversity Hospital, Bordeaux
- RECRUITINGNANCT07476651Scout Dose of Resin MicrospheresSeoul National University Hospital
- RECRUITINGPHASE2NCT06728410A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or RearrangementMehmet Akce
- RECRUITINGPHASE2NCT07223307REGULUS: MRI-guided Adaptive SABR for Liver CancersStanford University
- RECRUITINGPHASE2NCT07201519Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion ChemotherapyMichael J Cavnar, MD
- RECRUITINGPHASE2NCT07260175Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 CholangiocarcinomaInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- RECRUITINGNANCT06735560Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NENNantes University Hospital
- RECRUITINGNANCT07263217Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver InjurySecond Affiliated Hospital, School of Medicine, Zhejiang University